NYSE:SNN Smith & Nephew (SNN) Stock Forecast, Price & News $29.90 -0.09 (-0.30%) (As of 05/31/2023 ET) Add Compare Share Share Today's Range$29.66▼$30.0050-Day Range$27.38▼$32.7052-Week Range$21.77▼$33.08Volume826,036 shsAverage Volume852,499 shsMarket Capitalization$13.06 billionP/E RatioN/ADividend Yield3.01%Price TargetN/A ProfileProfileAnalyst RatingsChartCompetitorsDividendFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsDividendFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Smith & Nephew MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.30% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.12Based on 2 Articles This WeekInsider TradingN/AProj. Earnings Growth9.77%From $1.74 to $1.91 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.58 out of 5 starsMedical Sector892nd out of 1,006 stocksSurgical Appliances & Supplies Industry18th out of 19 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Smith & Nephew. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.30% of the float of Smith & Nephew has been sold short.Short Interest Ratio / Days to CoverSmith & Nephew has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Smith & Nephew has recently increased by 25.00%, indicating that investor sentiment is decreasing significantly. Previous Next 1.7 Dividend Strength Dividend YieldSmith & Nephew pays a meaningful dividend of 3.01%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthSmith & Nephew has only been increasing its dividend for 1 years.Dividend SustainabilityBased on earnings estimates, Smith & Nephew will have a dividend payout ratio of 47.12% next year. This indicates that Smith & Nephew will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SNN. Previous Next 2.3 News and Social Media Coverage News SentimentSmith & Nephew has a news sentiment score of 0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Smith & Nephew this week, compared to 1 article on an average week.MarketBeat Follows4 people have added Smith & Nephew to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Smith & Nephew insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.00% of the stock of Smith & Nephew is held by insiders.Percentage Held by InstitutionsOnly 9.11% of the stock of Smith & Nephew is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Smith & Nephew are expected to grow by 9.77% in the coming year, from $1.74 to $1.91 per share.Price to Earnings Growth RatioSmith & Nephew has a PEG Ratio of 1.94. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSmith & Nephew has a P/B Ratio of 2.48. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Smith & Nephew (NYSE:SNN) StockSmith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.Read More Receive SNN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter. Email Address SNN Stock News HeadlinesMay 18, 2023 | americanbankingnews.comReviewing Smith & Nephew (NYSE:SNN) & LogicMark (NASDAQ:LGMK)May 15, 2023 | americanbankingnews.comSmith & Nephew plc (NYSE:SNN) Sees Large Drop in Short InterestJune 1, 2023 | Chaikin Analytics (Ad)Wall Street Legend Who Called AMZN Crash Issues New Sell AlertNow, after years of big gains, he says one popular company's day in the sun is finally coming to an end. You must get off this sinking ship – NOW. 1 million people follow him for his surprisingly accurate predictions. His new sell alert could save your wealth in 2023.May 12, 2023 | americanbankingnews.comAnalysts Set Smith & Nephew plc (NYSE:SNN) Price Target at $1,000.00May 4, 2023 | marketwatch.comSmith & Nephew falls Thursday, still outperforms marketApril 27, 2023 | msn.comSmith & Nephew reports strong first quarter growth with £44m sales upliftApril 27, 2023 | americanbankingnews.comSmith & Nephew (NYSE:SNN) Lowered to Hold at HSBCApril 17, 2023 | americanbankingnews.comSmith & Nephew plc (NYSE:SNN) Receives $1,000.00 Consensus Price Target from BrokeragesJune 1, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...April 14, 2023 | forbes.comSmith & Nephew (SNN) Buy Write Still Good To GoApril 13, 2023 | forbes.comSmith & Nephew Buy WriteApril 11, 2023 | americanbankingnews.comSmith & Nephew (NYSE:SNN) Upgraded at Morgan StanleyMarch 31, 2023 | thestreet.comSmith & Nephew Stock To Go Ex-dividend Tomorrow (SNN)March 29, 2023 | americanbankingnews.comSmith & Nephew (NYSE:SNN) Cut to Underweight at BarclaysMarch 26, 2023 | finance.yahoo.comHere's Why We're Wary Of Buying Smith & Nephew's (LON:SN.) For Its Upcoming DividendMarch 23, 2023 | finance.yahoo.comNew evidence demonstrates Smith+Nephew's COBLATION™ Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniquesMarch 23, 2023 | americanbankingnews.comSmith & Nephew plc (NYSE:SNN) Receives $1,240.00 Consensus Target Price from AnalystsMarch 14, 2023 | marketwatch.comSmith & Nephew rises Tuesday, outperforms marketMarch 13, 2023 | marketwatch.comSmith & Nephew outperforms market despite losses on the dayMarch 9, 2023 | finance.yahoo.comSmith & Nephew (SNN) Simplifies ACL Surgery With New OffersMarch 8, 2023 | finance.yahoo.comSmith+Nephew to highlight procedural innovations in Sports Medicine during AAOS 2023 Annual MeetingFebruary 24, 2023 | seekingalpha.comSmith & Nephew: Flat FY22 Growth, Now An Execution StoryFebruary 24, 2023 | finance.yahoo.comInvestors’ Chronicle: Antofagasta, Hays, Smith & NephewFebruary 23, 2023 | finance.yahoo.comWhat Makes Smith & Nephew (SNN) a New Buy StockFebruary 21, 2023 | msn.comSmith & Nephew profits shrink amid major fall in Bioventus holdingFebruary 17, 2023 | msn.comSmith & Nephew reveals Rupert Soames will become next chairmanFebruary 17, 2023 | msn.comMedical devices maker Smith & Nephew reveals ex-Serco head Rupert Soames will become next chairmanSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SNN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter. Email Address SNN Company Calendar Last Earnings11/17/2014Ex-Dividend for 5/17 Dividend3/30/2023Dividend Payable5/17/2023Today5/31/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNYSE:SNN CUSIPN/A CIK845982 Webwww.smith-nephew.com Phone441923477100Fax44-20-7930-3353Employees19,012Year Founded1856Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio17.18 P/E Growth1.94Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.52 Current Ratio2.25 Quick Ratio0.96 Sales & Book Value Annual Sales$5.22 billion Price / Sales2.50 Cash Flow$3.04 per share Price / Cash Flow9.84 Book Value$12.08 per share Price / Book2.48Miscellaneous Outstanding Shares436,688,000Free Float432,321,000Market Cap$13.06 billion OptionableOptionable Beta0.60 Social Links Key ExecutivesDeepak S NathChief Executive Officer & DirectorPaul ConnollyPresident-Global OperationsAnne-Francoise NesmesChief Financial Officer & Executive DirectorAlison ParkesChief Compliance OfficerPhilip G. CowdyChief Business Development OfficerKey CompetitorsSTERISNYSE:STEAlign TechnologyNASDAQ:ALGNZimmer BiometNYSE:ZBHEdwards LifesciencesNYSE:EWBio-TechneNASDAQ:TECHView All CompetitorsInstitutional OwnershipAmeriprise Financial Inc.Bought 29,199 shares on 5/22/2023Ownership: 0.009%JPMorgan Chase & Co.Bought 630,525 shares on 5/18/2023Ownership: 0.151%New York State Common Retirement FundSold 19,033 shares on 5/18/2023Ownership: 0.016%SkyView Investment Advisors LLCBought 8,021 shares on 5/18/2023Ownership: 0.002%Boston Common Asset Management LLCBought 497 shares on 5/17/2023Ownership: 0.002%View All Institutional Transactions SNN Stock - Frequently Asked Questions Should I buy or sell Smith & Nephew stock right now? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 2 sell ratings, 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SNN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SNN, but not buy additional shares or sell existing shares. View SNN analyst ratings or view top-rated stocks. How have SNN shares performed in 2023? Smith & Nephew's stock was trading at $26.89 at the start of the year. Since then, SNN stock has increased by 11.2% and is now trading at $29.90. View the best growth stocks for 2023 here. Are investors shorting Smith & Nephew? Smith & Nephew saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 1,300,000 shares, an increase of 25.0% from the April 30th total of 1,040,000 shares. Based on an average daily trading volume, of 931,300 shares, the days-to-cover ratio is currently 1.4 days. Approximately 0.3% of the shares of the stock are sold short. View Smith & Nephew's Short Interest. How were Smith & Nephew's earnings last quarter? Smith & Nephew plc (NYSE:SNN) issued its earnings results on Monday, November, 17th. The medical equipment provider reported $0.98 EPS for the quarter, topping analysts' consensus estimates of $0.39 by $0.59. How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew? Smith & Nephew declared a semi-annual dividend on Monday, February 27th. Shareholders of record on Friday, March 31st will be given a dividend of $0.462 per share on Wednesday, May 17th. This represents a yield of 2.6%. The ex-dividend date of this dividend is Thursday, March 30th. This is a positive change from the stock's previous semi-annual dividend of $0.29. Read our dividend analysis for SNN. What ETFs hold Smith & Nephew's stock? ETFs with the largest weight of Smith & Nephew (NYSE:SNN) stock in their portfolio include ALPS Disruptive Technologies ETF (DTEC).SPDR S&P Kensho New Economies Composite ETF (KOMP). Is Smith & Nephew a good dividend stock? Smith & Nephew (NYSE:SNN) pays an annual dividend of $0.90 per share and currently has a dividend yield of 3.01%. Read our dividend analysis for SNN. What other stocks do shareholders of Smith & Nephew own? Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Smith & Nephew (SN), RPM International (RPM), Gilead Sciences (GILD), AbbVie (ABBV), Alibaba Group (BABA), Johnson & Johnson (JNJ), Pfizer (PFE), Abbott Laboratories (ABT), Alexion Pharmaceuticals (ALXN) and Amgen (AMGN). What is Smith & Nephew's stock symbol? Smith & Nephew trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN." Who are Smith & Nephew's major shareholders? Smith & Nephew's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Nuance Investments LLC (2.43%), Arrowstreet Capital Limited Partnership (0.59%), Scharf Investments LLC (0.51%), FMR LLC (0.46%), Bank of America Corp DE (0.23%) and Envestnet Asset Management Inc. (0.19%). How do I buy shares of Smith & Nephew? Shares of SNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Smith & Nephew's stock price today? One share of SNN stock can currently be purchased for approximately $29.90. How much money does Smith & Nephew make? Smith & Nephew (NYSE:SNN) has a market capitalization of $13.06 billion and generates $5.22 billion in revenue each year. How many employees does Smith & Nephew have? The company employs 19,012 workers across the globe. How can I contact Smith & Nephew? Smith & Nephew's mailing address is BUILDING 5 CROXLEY PARK HATTERS LANE, WATFORD X0, WD18 8YE. The official website for the company is www.smith-nephew.com. The medical equipment provider can be reached via phone at 441923477100, via email at andrew.swift@smith-nephew.com, or via fax at 44-20-7930-3353. This page (NYSE:SNN) was last updated on 6/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smith & Nephew plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.